Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,565,615
+$7,429,679 QoQ
Shares Held
322,838
+36.6% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#98
of 755 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WORLDQUANT MILLENNIUM ADVISORS LLC holds $380,210,326 across 20 Biotechnology names. EXEL ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
353,970 | $220,714,453 | |
| 2 | INCY |
Incyte Corp
|
486,810 | $55,184,781 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
62,180 | $18,718,045 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
322,838 | $17,565,615 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
72,619 | $13,600,086 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
55,396 | $13,348,774 | |
| 7 | INSM |
INSMED Inc
|
69,199 | $7,377,997 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
214,374 | $7,157,947 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,565,615 | 322,838 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $10,135,936 | 236,324 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,277,558 | 188,856 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,806,122 | 116,371 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,779,110 | 85,733 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $272,986 | 7,394 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $247,252 | 7,425 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||